David Bar-Or Net Worth

David Bar-Or biography

Dr. David Bar-Or M.D. serves as Director of the Company. Dr. Bar-Or served as our Chief Scientific Officer from March 2010 until September 2018. Dr. Bar-Or also served as our Dr. Bar-Or served as our Chief Scientific Officer (“CSO”) from March 2010 until September 2018. Dr. Bar-Or also served as our chairman of the Board from March 2010 until May 2010. From April 2009 until March 2010, he served as Chairman of the Board and CSO of DMI Life Sciences, Inc. Dr. Bar-Or is currently the owner of Trauma Research, LLC and the director of Trauma Research at Swedish Medical Center, Englewood, Colorado, St. Anthony’s Hospital, Lakewood, Colorado, Penrose Hospital, Colorado Springs, Colorado, Research Medical Center, Kansas City, Missouri, Wesley Medical Center, Wichita, Kansas and The Medical Center of Plano, Plano, Texas. Dr. Bar-Or is the founder of Ampio Pharmaceuticals, Inc. Dr. Bar-Or was principally responsible for all patented and proprietary technologies acquired by us from DMI BioSciences, Inc. in April 2009. He was also responsible for all patents issued and applied for since then, having been awarded over 500 patents and having been an inventor on almost 120 patent applications. Dr. Bar-Or has authored or co-authored over 180 peer-reviewed journal articles and several book chapters. Dr. Bar-Or is a reviewer for over 45 peer reviewed scientific and clinical journals. He is the recipient of the Gustav Levi Award from the Mount Sinai Hospital, New York, New York, the Kornfeld Award for an outstanding MD Thesis, the Outstanding Resident Research Award from the Denver General Hospital, and the Outstanding Clinician Award for the Denver General Medical Emergency Resident Program. Dr. Bar-Or received his medical degree from The Hebrew University, Hadassah Medical School, Jerusalem, Israel, following which he completed a biochemistry fellowship at Hadassah Hospital under Professor Alisa Gutman and undertook post-graduate residency training at Denver Health Medical Center, specializing in emergency medicine, a discip

What is the salary of David Or?

As the Director of Ampio Pharmaceuticals Inc, the total compensation of David Or at Ampio Pharmaceuticals Inc is $228,218. There are 6 executives at Ampio Pharmaceuticals Inc getting paid more, with Michael E. Macaluso having the highest compensation of $457,040.

How old is David Or?

David Or is 71, he's been the Director of Ampio Pharmaceuticals Inc since 2018. There are 1 older and 10 younger executives at Ampio Pharmaceuticals Inc. The oldest executive at Ampio Pharmaceuticals Inc is Philip Coelho, 75, who is the Independent Director.

What's David Or's mailing address?

David's mailing address filed with the SEC is C/O AMPIO PHARMACEUTICALS, INC., 373 INVERNESS PARKWAY, SUITE 200, ENGLEWOOD, CO, 80112.

Insiders trading at Ampio Pharmaceuticals Inc

Over the last 13 years, insiders at Ampio Pharmaceuticals Inc have traded over $202,762 worth of Ampio Pharmaceuticals Inc stock and bought 377,748 units worth $116,063 . The most active insiders traders include Philip H Coelho, Joshua R. Disbrow e J Kevin Buchi. On average, Ampio Pharmaceuticals Inc executives and independent directors trade stock every 192 days with the average trade being worth of $74. The most recent stock trade was executed by J Kevin Buchi on 9 June 2023, trading 21,858 units of AMPE stock currently worth $6,339.

What does Ampio Pharmaceuticals Inc do?

ampio pharmaceuticals inc (ampe) is a biotechnology company located in 5445 dtc pkwy, greenwood village, colorado, united states.

Ampio Pharmaceuticals Inc executives and stock owners

Ampio Pharmaceuticals Inc executives and other stock owners filed with the SEC include:

• Michael E. Macaluso,
  Founder, Chairman & CEO (Leave of Absence )
• Daniel G. Stokely CPA, CPA,
  CFO, Corp. Sec. & Treasurer
• Holli Cherevka,
  Chief Operating Officer
• Daniel Stokely,
  Chief Financial Officer, Treasurer, Secretary
• Michael Macaluso,
  Chairman of the Board, Chief Executive Officer
• Holli Cherevka,
  Pres & COO
• David Bar-Or,
  Director
• David Stevens,
  Independent Director
• Richard Giles,
  Independent Director
• Philip Coelho,
  Independent Director
• Laura Goldberg,
  VP of Quality and Regulatory Operations
• April Ramirez,
  Clinical Trial Mang.
• Lane Hapke,
  VP of Manufacturing Operations
• Dr. Howard Levy M.B.B.Ch., M.M.M., Ph.D.,
  Chief Medical Officer
• Michael A. Martino,
  CEO & Chairman
• Michael A Martino,
  CEO
• J Kevin Buchi,
  Director
• Vaughan Lennox Clift,
  Chief Regulatory Affairs
• Gregory A Gould,
  Chief Financial Officer
• Iii Thomas E. Chilcott,,
  Chief Financial Officer
• Dan Stokely,
  CFO
• Mark D Mc Gregor,
  Chief Financial Officer
• Joshua R. Disbrow,
  Chief Operating Officer
• Elizabeth Varki Jobes,